MV Capital Management’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
Other funds holding JAZZ
MV Capital Management's JAZZ Position: Q2 2026 in Review
MV Capital Management opened a new position in Jazz Pharmaceuticals (JAZZ) in Q2 2026: 1 share worth $241. The stake represents ﹤0.01% of the portfolio and ranks #1127 among its holdings. This is a return to the name: MV Capital Management previously reported a position in JAZZ as recently as Q1 2025.
MV Capital Management first reported a position in JAZZ in Q2 2024 and has held it in 5 quarters since. The position peaked at $1.35K in Q4 2024. 646 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.
- MV Capital Management held 1 share of Jazz Pharmaceuticals worth $241 as of Q2 2026.
- Jazz Pharmaceuticals was a new MV Capital Management position in Q2 2026.
- Jazz Pharmaceuticals made up ﹤0.01% of MV Capital Management's portfolio in Q2 2026, its #1127 holding.
- MV Capital Management first reported a position in Jazz Pharmaceuticals in Q2 2024 and has held it in 5 quarters since.
- MV Capital Management's Jazz Pharmaceuticals position peaked at $1.35K in Q4 2024.
- 646 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.
Based on MV Capital Management's 13F filing for Q2 2026, filed 29 Jul 2026.